Finanzielle Vergleiche Samsung Biologics Co.,Ltd.

Aktien

A207940

KR7207940008

A207940

Pharmazeutika

Schlusskurs Korea S.E. 13.01.2026 % 5 Tage Veränd. 1. Jan.
1’908’000.00 KRW +2.64% Intraday Chart für Samsung Biologics Co.,Ltd. +90.80% +90.80%
Hauptkonkurrenten
Umsatz (Y-1) Nettogewinn (Y-1) EBIT-Marge (Y-1) ROE (Y-1) ROA (Y-1) Verschuldungsgrad (Y-1)
3.08 Mrd. 23.82%29.03%10.45%6.49%0.1x
14.2 Mrd. 31.07%36.7%19.23%15.02%-1.11x
6.37 Mrd. 17.31%13.59%11.21%6.48%0.99x
15.56 Mrd. 19.3%28.72%16.36%7.75%1.74x
9.68 Mrd. 16.87%31.16%10.36%5.95%1.06x
4.24 Mrd. 0.77%9.76%5.27%3.72%-4.29x
1.29 Mrd. -1%-8.02%-0.74%-0.45%-11.4x
69.63 Mio. 59.01%24.7%28.77%18.72%-6.16x
222 Mio. -241.44%-267.22%35.11%-73.11%-1.77x
681 Mio. -10.97%-17.14%-8.58%-7.13%8.63x
3.24 Mrd. -110.04%-121.91%-28.77%-21.87%1.87x
2.35 Mrd. 14.93%22.42%10.9%5.41%1.59x
2.85 Mrd. 14.96%16.97%8.05%6.17%-0.93x
10.9 Mio. -2’957.71%-3’477.43%-33.47% - 3.99x
1.25 Mrd. 22.95%28.06%14.19%8.74%0.28x
386 Mio. -74.47%-72.74%-231.63%-49.66%0.49x
308 Mio. 4.73%4.18%0.85% - -5.29x
7.47 Mrd. 2.18%18.81%2.79%0.74%5.16x
291 Mio. 30.69%22.61%10.34% - -8.45x
Durchschnitt 3.87 Mrd. -165.11% -193.57% -6.28% -4.19% -0.71x
Gewichteter Durchschnitt nach Marktkapitalisierung 6.86 Mrd. -65.79% -77.1% 5.75% 2.87% -0.47x
Biopharmazeutika